CompoAtlas

Whole Food Multivitamin for Women

Texto original en francés.

Producto de salud natural autorizado en Canadá

Si este producto se vendiera en Francia

Solo se calcula una cantidad diaria para una posología oral explícita para adultos, expresada por día y en una unidad sólida correspondiente a la forma del producto. No se extrapolan las unidades ambiguas, los líquidos, los polvos ni las dosis pediátricas. Una cantidad no calculada no se compara con los límites de dosis. Este análisis no constituye una autorización de venta en Francia ni una evaluación de seguridad o eficacia.

Composición

Ingrediente medicinal y fuentePor unidad posológica, según la fuenteMáximo diario, adulto
Chrome

Fuente : Produit de chélation chromique et de protéine végétale hydrolysée (PVH)

8,75 mcg35 µg
Vitamine B6

Fuente : Pyridoxal 5'-phosphate

1 mg4.000 µg
Vitamin K2

Fuente : Ménaquinone 7

27,5 mcg110 µg
Vaccinium macrocarpon

Fuente : Fruit

6,25 mgNo calculada
Iode

Fuente : Fucus vesiculosus - Thalle

37,5 mcg150 µg
Riboflavine

Fuente : Riboflavine

0,75 mg3.000 µg
(3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol

Fuente : Oléorésine de tagetes erecta

0,625 mgNo calculada
Lycopène tout trans

Fuente : Solanum lycopersicum (fruit flesh), isolate

0,75 mgNo calculada
4-alpha-D-Glucane glucanohydrolase

Fuente : Aspergillus niger - En entier

8,75 mgNo calculada
4-alpha-D-Glucane glucanohydrolase

Fuente : Aspergillus niger - En entier

7.500 FCC DUNo calculada
3,3'-dihydroxy-4,4'-diketo-bêta-carotène

Fuente : Haematococcus pluvialis - whole

100 mgNo calculada
4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase

Fuente : Trichoderma reesei - en entier

4,5 mgNo calculada
4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase

Fuente : Trichoderma reesei - en entier

250 FCC CUNo calculada
(3R,3'R)-bêta,bêta-Carotène-3,3'-diol

Fuente : Oléorésine de tagetes erecta

125 mgNo calculada
3-(O-6-désoxy-alpha-l-mannopyranosyl-(1-6)-bêta-d-glucopyranosyloxy)-2-(3,4-dihydroxyphényl)-5,7-dihydroxy-4H-chromen-4-one

Fuente : Citrus sinensis - feuille

2,25 mgNo calculada
Beta vulgaris

Fuente : Racine

6,25 mgNo calculada
bêta-carotène

Fuente : bêta-carotène

225 mcgNo calculada
Biotine

Fuente : Biotine

15 mcg60 µg
Boron

Fuente : Citrate de bore

150 mcgNo calculada
Brassica oleracea var. italica

Fuente : Sommité (herbe)

6,25 mgNo calculada
Brassica oleracea var. viridis

Fuente : Feuille

6,25 mgNo calculada
Calcium

Fuente : Citrate de calcium

50 mg200.000 µg
Camellia sinensis

Fuente : Feuille

Potencia : 45 % Catechins

10 mgNo calculada
Choline

Fuente : Lecithin

5 mgNo calculada
Cinnamomum verum

Fuente : Écorce de racine

7,5 mgNo calculada
2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl

Fuente : Procédé de fermentation à l'aide de bactéries et/ou de levures

1,5 mgNo calculada
Cuivre

Fuente : Produit de chélation de composé cuivrique et de PVH

0,225 mcg0,9 µg
Curcuma longa

Fuente : Rhizome Extract

Extracto : Matériel brut sec

Relación de extracción : 4:1

Equivalente de planta seca : 30 mg

7,5 mgNo calculada
Daucus carota

Fuente : Racine

6,25 mgNo calculada
Folate

Fuente : 5-Méthyltétrahydrofolate

100 mcgNo calculada
Ginkgo biloba

Fuente : Feuille

Potencia : 0 5-7% terpene flavonoids

5 mgNo calculada
Ginkgo biloba

Fuente : Feuille

Potencia : 0 22-27% flavonoid glycosides

No especificadaNo calculada
Inositol

Fuente : Inositol

4,75 mgNo calculada
Fer

Fuente : Fumarate ferreux

3,5 mg14.000 µg
bêta-D-galactoside galactohydrolase

Fuente : Aspergillus flavus var. oryzae - En entier

0,5 mgNo calculada
bêta-D-galactoside galactohydrolase

Fuente : Aspergillus flavus var. oryzae - En entier

250 FCC LUNo calculada
Magnésium

Fuente : Citrate de magnésium

75 mg300.000 µg
Manganèse

Fuente : Sulfate de manganèse (II)

0,45 mg1.800 µg
Molybdène

Fuente : Citrate de molybdène (VI)

11,25 mcg45 µg
Molybdène

Fuente : Succinate de molybdène (VI)

11,25 mcg45 µg
Molybdène

Fuente : Malate de molybdène (VI)

11,25 mcg45 µg
Molybdène

Fuente : Fumarate de molybdène (VI)

11,25 mcg45 µg
Molybdène

Fuente : Glutarate de molybdène (VI)

11,25 mcg45 µg
Niacine

Fuente : Niacinamide

5 mgNo calculada
Acide pantothénique

Fuente : Acide D-pantothénique

2,25 mg9.000 µg
Phosphorus

Fuente : Phosphate de calcium, monobasique

31,25 mg125.000 µg
Potassium

Fuente : Chlorure de potassium

12,5 mg50.000 µg
Protéase fongique

Fuente : Aspergillus flavus var. oryzae - En entier

11,25 mgNo calculada
Protéase fongique

Fuente : Aspergillus flavus var. oryzae - En entier

62.500 FCC HUTNo calculada
Punica granatum

Fuente : Fruit

6,25 mgNo calculada
Rubus ideaus

Fuente : Fruit

6,25 mgNo calculada
Sélénium

Fuente : Sélénométhionine

13,75 mcg55 µg
Spinacia oleracea

Fuente : Feuille

6,25 mgNo calculada
Thiamine

Fuente : Benfotiamine

0,75 mg3.000 µg
Trans-resvératrol

Fuente : Vitis vinifera - Fruit

1 mgNo calculada
Triacylglycérol lipase

Fuente : Aspergillus niger - En entier

7,5 mgNo calculada
Vaccinium angustifolium

Fuente : Fruit

6,25 mgNo calculada
Vitamine B12

Fuente : Méthylcobalamine

1,5 mcg6 µg
Vitamine C

Fuente : Acide ascorbique

37,5 mg150.000 µg
Vitamine D

Fuente : Cholécalciférol

6,25 mcg25 µg
Vitamine D

Fuente : Cholécalciférol

250 UI25 µg
Vitamine E

Fuente : d-alpha tocophérol

7,45 UINo calculada
Vitamine E

Fuente : d-alpha tocophérol

4,9915 mg ATNo calculada
Zinc

Fuente : Produit de chélation de zinc et de protéine végétale hydrolysée (PVH)

2,75 mg11.000 µg

Ingredientes no medicinales

Cellulose microcristalline

Dosis recomendadas en Canadá

PoblaciónEdadCantidad por tomaFrecuencia
AdultesNon précisée4 Capsule1 Tous les jours

Usos autorizados en Canadá

Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may reduce the risk of developing osteoporosis (in peri- and postmenopausal women) (in later life). Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis (In peri- and postmenopausal women) (in later life). An antioxidant. Calcium intake, when combined with sufficient Vitamin D, a healthy diet and regular exercise may reduce the risk of developing osteoporosis. Digestive aid. Digestive enzyme. Helps digest proteins. Helps in collagen formation to maintain healthy bones, cartilage, teeth and/or gums. Helps in connective tissue formation. Helps in energy metabolism and in tissue formation. Helps in energy production. Helps in the absorption and use of calcium and phosphorus. Helps in the development and maintenance of bones and teeth (especially in childhood, adolescence and young adulthood). Helps in the development and maintenance of bones, cartilage, teeth and/or gums. Helps in the function of the thyroid gland. Helps in the normal function of the immune system. Helps In the process of normal cell division. Helps in the process of normal regulation of cell division and specialization. Helps in tissue formation. Helps in wound healing. Helps normal growth and development. Helps to build strong bones and teeth. Helps to form red blood cells. Helps to maintain cognitive functions. Helps to maintain healthy bones, hair, nail, mucous membranes and/or skin. Helps to maintain immune function. Helps to maintain normal acid-base metabolism. Helps to maintain normal blood glucose levels. Helps to maintain normal DNA synthesis. Helps to maintain normal electrolyte balance. Helps to maintain normal function of the thyroid gland. Helps to maintain normal iron transport in the body. Helps to maintain normal metabolism of iron. Helps to maintain nonTial muscle function. Helps to maintain normal production of thyroid hormones.

Texto original en inglés.

Helps to maintain nonTial red blood cells. Helps to maintain proper muscle function, including the heart muscle. Helps to maintain the body's ability to metabolize nutrients. Helps to prevent biotin deficiency. Helps to prevent pantothenic acid deficiency. Helps to prevent riboflavin deficiency. Helps to prevent thiamine deficiency. Helps to prevent vitamin B12 deficiency. Helps to prevent vitamin B3 deficiency. Helps to prevent vitamin B6 deficiency. Helps to prevent vitamin C deficiency. Helps to prevent vitamin D deficiency. Helps to prevent vitamin E deficiency. Helps to prevent vitamin K deficiency. Helps to produce and repair connective tissue. Provides antioxidants for the maintenance of good health. Provides antioxidants. Provides support for healthy glucose metabolism. Provitamin A for the maintenance of good health. Provitamin A to help in the development and maintenance of bones and teeth. Provitamin A to help in the development and maintenance of night vision. Provitamin A to help maintain eyesight, skin, membranes and immune function. Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of antioxldant(s)/Provides antioxidant(s). Source of/An antioxidant for the maintenance of good health. Source of/An antioxidant that decreases the adverse effects of free radicals on nonTial physiological functions. Source of/An antioxidant that helps (to): a) fight/ b) protect (cells) against I c) reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of/An antioxidant that helps protect against oxidative stress. Source of/An antioxidant that helps to reduce free radicals and lipid oxidation in body tissues. Source of/An antioxidant that protects the fat in body tissues from oxidation. Source of/An electrolyte for the maintenance or good health. Helps to form red blood cells and helps in their proper function. Helps to reduce tiredness and fatigue caused by iron deficiency anemia.

Texto original en inglés.

Un uso autorizado en Canadá no es una declaración de propiedades saludables autorizada en la Unión Europea. Consulte el registro de declaraciones de propiedades saludables.

Advertencias en Canadá

Cautions and Warnings : Consult a health care practitioner prior to use if you are breastfeeding, or if you are taking medications for diabetes, high blood pressure, or seizures, or if you are taking blood thinners or if you have a history of kidney stones, or if you have gallstones or a bile duct obstruction, or if you have stomach ulcers or excess stomach acid, or if you have a gastrointestinal lesion/ulcer, are taking an anticoagulant/blood thinner or an anti-inflammatory, or are having surgery, or if you have an iron deficiency, or if you have diabetes. Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding. For prolonged use, consult a health care practitioner. For use beyond 12 weeks, consult a health care practitioner. Headaches, heartburn, bloating and hypersensitivity (e.g. allergy) have been known to occur; in which case, discontinue use. Hypersensitivity/allergy has been known to occur; in which case discontinue use. If pregnant, do not use this product. If symptoms persist or worsen, consult a health care practitioner. If you are taking prescription medication, consult a health care practitioner prior to use as resveratrol may alter the effectiveness of these medications. If you have a liver disorder, consult a health care practitioner prior to use. Stop use if you develop symptoms of liver trouble such as yellowing of the skin/eyes (jaundice), stomach pain, dark urine, sweating, nausea, unusual tiredness and/or loss of appetite and consult a health care practitioner. Rare, unpredictable cases of liver injury associated with green tea extract-containing products have been reported (in Canada and internationally). Store in tightly sealed, light- and oxygen-resistant container in a cool, dry place. Keep out of reach of children. There is enough iron in this package to seriously harm a child.

Texto original en inglés.

Ficha del producto

Titular
NATURELO PREMIUM SUPPLEMENTS INC.
NPN o DIN-HM
80088473
Estado
Licencia no activa
Fecha de licencia
26 de septiembre de 2018
Fecha de revisión
12 de octubre de 2018
Forma
Capsule
Vía de administración
Orale
Tipo de solicitud
Non traditionnelle

Fuente

Ficha oficial de Health Canada, licencia 80088473

Base de datos de productos de salud natural autorizados (BDPSNH), Health Canada: productos autorizados, ingredientes, dosis, usos y advertencias, consultado el 27 de octubre de 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Texto original en inglés.

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Texto original en francés.

La fórmula vendida en Europa con el mismo nombre puede ser diferente. Esta información no sustituye el consejo de un médico o farmacéutico.

Advertencias oficiales (Health Canada)

Health Canada publica advertencias sobre estos ingredientes:

  • Vaccinium macrocarpon
    Leer la advertencia, cuándo se aplica y los estudios citados

    Texto original oficial en inglés.

    CRANBERRY - VACCINIUM MACROCARPON

    Vía de administración: Oral

    Precauciones y advertencias

    Condición de aplicación: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).

    Fuentes citadas por Health Canada (2)
    • Gettman MT, Ogan K, Brinkley LJ, Adams-Huet B, Pak CYC, Pearle MS. Effect of cranberry juice consumption on urinary stone risk factors. The Journal of Urology 2005;174(2):590-594. PubMed Ensayo aleatorizado
    • Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 2001;57(1):26-29. PubMed

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).

    Fuentes citadas por Health Canada (4)
    • Aston JL, Lodolce AE, Shapiro NL. Interaction between warfarin and cranberry juice. Pharmacotherapy 2006;26(9):1314-1319. PubMed
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Grant P. Warfarin and cranberry juice: an interaction? The Journal of Heart Valve Disease 2004;13(1):25-26. PubMed Caso clínico
    • Rindone JP, Murphy TW. Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. American Journal of Therapeutics 2005;13(3):283-284.

    Condición de aplicación: (Recurrent) urinary tract infection.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Monografía de Health Canada del 27 de marzo de 2026

    DRIED CRANBERRY JUICE

    Vía de administración: Oral

    Precauciones y advertencias

    Condición de aplicación: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).

    Fuentes citadas por Health Canada (2)
    • Gettman MT, Ogan K, Brinkley LJ, Adams-Huet B, Pak CYC, Pearle MS. Effect of cranberry juice consumption on urinary stone risk factors. The Journal of Urology 2005;174(2):590-594. PubMed Ensayo aleatorizado
    • Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 2001;57(1):26-29. PubMed

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).

    Fuentes citadas por Health Canada (4)
    • Aston JL, Lodolce AE, Shapiro NL. Interaction between warfarin and cranberry juice. Pharmacotherapy 2006;26(9):1314-1319. PubMed
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Grant P. Warfarin and cranberry juice: an interaction? The Journal of Heart Valve Disease 2004;13(1):25-26. PubMed Caso clínico
    • Rindone JP, Murphy TW. Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. American Journal of Therapeutics 2005;13(3):283-284.

    Condición de aplicación: (Recurrent) urinary tract infection.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Monografía de Health Canada del 27 de marzo de 2026

  • Cinnamomum verum
    Leer la advertencia, cuándo se aplica y los estudios citados

    Texto original oficial en inglés.

    Cinnamon - Cinnamomum Verum

    Vía de administración: Oral

    Precauciones y advertencias

    Condición de aplicación: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Blumenthal et al. 2000; WHO 1999).

    Fuentes citadas por Health Canada (4)
    • Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): American Botanical Council. 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • WHO 1999: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 1. Geneva (CH): World Health Organization; 1999.
    • OMS 1999: Organisation mondiale de la santé (OMS). Monographs on Selected Medicinal Plants : Volume 1. Geneva (CHE) : Organisation mondiale de la santé.

    Condición de aplicación: All products except antioxidants.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindicaciones

    Do not use if you are pregnant (Brinker 2010; BHC 2006; Blumenthal 2000).

    Fuentes citadas por Health Canada (3)
    • Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): American Botanical Council. 2000.
    • BHC 2006: Bradley PR, editor. British Herbal Compendium Volume 2: A Handbook of Scientific Information on Widely Used Plant Drugs—Companion to the British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 2006.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Monografía de Health Canada del 26 de julio de 2024

  • Curcuma longa
    Leer la advertencia, cuándo se aplica y los estudios citados

    Texto original oficial en inglés.

    TURMERIC - CURCUMA LONGA - Oral

    Vía de administración: Oral (ESCOP 2003; Blumenthal et al. 2000)

    Precauciones y advertencias

    Condición de aplicación: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (ESCOP 2003; Brinker 2001; McGuffin et al. 1997).

    Fuentes citadas por Health Canada (2)
    • ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.

    1 estudio citado en el texto no tiene referencia correspondiente en la monografía (véanse las anomalías en la página de fuentes).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder (HC 2025; EMA 2018; Brinker 2010; ESCOP 2003; McGuffin et al. 1997).

    Fuentes citadas por Health Canada (6)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2018. European Medicines Agency. European Union herbal monograph on Curcuma longa L., rhizome. London (GB): EMA Committee on Herbal Medicinal Products (HMPC); 25 September 2018. [Accessed 2023 October 14] Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-curcuma-longa-l-rhizoma-revision-1_en.pdf
    • ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
    • SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications (HC 2025).

    Fuentes citadas por Health Canada (2)
    • HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
    • SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience any new symptoms including yellowing of the eyes or skin, dark urine, nausea, vomiting, stomach pain (HC 2025).

    Fuentes citadas por Health Canada (2)
    • HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
    • SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867

    Condición de aplicación: All uses except for Source of antioxidants and Hepatoprotectant.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Monografía de Health Canada del 26 de septiembre de 2025

    Turmeric -CURCUMA LONGA - Topical

    Precauciones y advertencias

    For external use only.

    When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

    Contraindicaciones

    Do not use on deep or puncture wounds, animal bites or serious burns.

    Monografía de Health Canada del 28 de febrero de 2025

  • Daucus carota
    Leer la advertencia, cuándo se aplica y los estudios citados

    Texto original oficial en inglés.

    CARROT - DAUCUS CAROTA SUBSP. SATIVUS

    Vía de administración: Oral

    Precauciones y advertencias

    Se aplica a los productos: providing more than 6,000 μg of beta-carotene, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are a tobacco smoker (Touvier et al. 2005; Omenn et al. 1996; ATBC 1994).

    Fuentes citadas por Health Canada (3)
    • ATBC (Alpha-tocopherol, beta-carotene cancer prevention) study group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The New England Journal of Medicine1994;330(15):1029-1035.
    • Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S, Hammar S. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New England Journal of Medicine 1996;334(18):1150-1155. PubMed Ensayo aleatorizado
    • Touvier M, Kess E, Clavel-Chapelon F, and Boutron-Rualt MC. Dual association of beta- carotene with risk of tobacco-related cancers in a cohort of French women. Journal of the National Cancer Institute 2005;97(18):1338-1344. PubMed

    Monografía de Health Canada del 30 de enero de 2026

  • Ginkgo biloba
    Leer la advertencia, cuándo se aplica y los estudios citados

    Texto original oficial en inglés.

    GINKGO - GINKGO BILOBA

    Vía de administración: Oral

    Precauciones y advertencias

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).

    Fuentes citadas por Health Canada (3)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
    • WHO 1999: World Health Organization. WHO monographs on selected medicinal plants, Volume 1. Geneva (CHE): World Health Organization; 1999.
    • OMS 1999 : Organisation mondiale de la santé (OMS). Monographs on selected medicinal plants, Volume 1. Genève (CHE): Organisation mondiale de la santé; 1999.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).

    Fuentes citadas por Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Contraindicaciones

    Do not use if you are having a surgery (Gardner and McGuffin 2013).

    Fuentes citadas por Health Canada (1)
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).

    Fuentes citadas por Health Canada (3)
    • Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. Journal of General Internal Medicine 2005;20(7):657-661. PubMed Revisión sistemática
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Monografía de Health Canada del 25 de julio de 2025

  • Punica granatum
    Leer la advertencia, cuándo se aplica y los estudios citados
  • Vaccinium angustifolium
    Leer la advertencia, cuándo se aplica y los estudios citados

    Texto original oficial en inglés.

    Blueberry

    Vía de administración: Oral

    Precauciones y advertencias

    Se aplica a los productos: providing 5 grams or more of total dried fruit, per day; Products providing 37.5 grams or more of total fresh fruit, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (ASHP 2005; Franco et al. 2004; IOM 2001; Hansten et al. 1997).

    Fuentes citadas por Health Canada (4)
    • ASHP 2005: American Society of Health-System Pharmacists. American Hospital Formulary Service (AHFS) Drug Information. Philadelphia (PA): Lippincott Williams and Wilkins; 2005.
    • Franco V, Polanczyk CA, Clausell N, Rohde LE. Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. The American Journal of Medicine 2004;166(10):651-656. PubMed Ensayo aleatorizado
    • Hansten PD, Horn JR, editors. Drug Interactions Analysis and Management. Vancouver (WA): Applied Therapeutics Inc.; 1997.
    • IOM 2001: Institute of Medicine. Panel on Micronutrients, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington (DC): National Academies Press; 2001.

    Monografía de Health Canada del 29 de agosto de 2025

  • Vitamine D
    Leer la advertencia, cuándo se aplica y los estudios citados

    Texto original oficial en inglés.

    VITAMIN D (>1,000 - 2,500 IU)

    Vía de administración: Oral

    Precauciones y advertencias

    Condición de aplicación: All products except products containing zinc sourced from picolinate requiring a contraindication.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condición de aplicación: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).

    Fuentes citadas por Health Canada (2)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).

    Fuentes citadas por Health Canada (3)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NNHPD 2021. Natural and Non-Prescription Health Products Directorate. Internal evidence and HC's product monographs.
    • DPSNSO 2021. Direction des produits de santé naturels et sans ordonnance. Preuves internes et monographies de produits internes de SC.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.

    Se aplica a los productos: containing vitamin K2.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).

    Fuentes citadas por Health Canada (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Se aplica a los productos: providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).

    Fuentes citadas por Health Canada (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Contraindicaciones

    Condición de aplicación: All products.

    Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).

    Fuentes citadas por Health Canada (2)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

    Se aplica a los productos: containing zinc sourced from picolinate.

    Do not use if you are pregnant or breastfeeding (NNHPD 2026).

    Fuentes citadas por Health Canada (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Reacciones adversas conocidas

    Condición de aplicación: All products.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).

    Fuentes citadas por Health Canada (2)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

    Se aplica a los productos: providing more than 350 mg of magnesium per day.

    When using this product you may experience diarrhea (NNHPD 2026).

    Fuentes citadas por Health Canada (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Monografía de Health Canada del 26 de junio de 2026

Se refieren al ingrediente, no a este producto ni a su dosis. No sustituyen el consejo médico.

Lista en la revisión oficial del (registro: Base de datos de productos de salud natural autorizados (BDPSNH), Health Canada: productos autorizados, ingredientes, dosis, usos y advertencias).

Fotografiar el envase

¿Alguna información inexacta o más reciente sobre este producto, sea usted lector o marca? Escriba a contact@compoatlas.com: cada corrección se publica en el registro de correcciones.

Lista registrada en 2018. Fotografíe el envase para comprobar si ha cambiado.

Intro para analizar, Mayús+Intro para una nueva línea